BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12877556)

  • 1. DNA topoisomerases I and II inhibitory activity of constituents isolated from Juglans mandshurica.
    Li G; Lee SY; Lee KS; Lee SW; Kim SH; Lee SH; Lee CS; Woo MH; Son JK
    Arch Pharm Res; 2003 Jun; 26(6):466-70. PubMed ID: 12877556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lignans from the bark of Machilus thunbergii and their DNA topoisomerases I and II inhibition and cytotoxicity.
    Li G; Lee CS; Woo MH; Lee SH; Chang HW; Son JK
    Biol Pharm Bull; 2004 Jul; 27(7):1147-50. PubMed ID: 15256759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and DNA topoisomerase inhibitory activity of constituents isolated from the fruits of Evodia officinalis.
    Xu ML; Li G; Moon DC; Lee CS; Woo MH; Lee ES; Jahng Y; Chang HW; Lee SH; Son JK
    Arch Pharm Res; 2006 Jul; 29(7):541-7. PubMed ID: 16903072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical constituents from the leaves of Juglans mandshurica.
    Yao DL; Zhang CH; Luo J; Jin M; Zheng MS; Cui JM; Son JK; Li G
    Arch Pharm Res; 2015 Apr; 38(4):480-4. PubMed ID: 24748532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four new diarylheptanoids from the roots of Juglans mandshurica.
    Li G; Xu ML; Choi HG; Lee SH; Jahng YD; Lee CS; Moon DC; Woo MH; Son JK
    Chem Pharm Bull (Tokyo); 2003 Mar; 51(3):262-4. PubMed ID: 12612408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new quinones from the roots of Juglans mandshurica.
    Jin M; Sun J; Li R; Diao S; Zhang C; Cui J; Son JK; Zhou W; Li G
    Arch Pharm Res; 2016 Sep; 39(9):1237-41. PubMed ID: 27397432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
    Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
    Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of topoisomerases by fatty acids.
    Suzuki K; Shono F; Kai H; Uno T; Uyeda M
    J Enzyme Inhib; 2000; 15(4):357-66. PubMed ID: 10995067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA topoisomerases I and II and cytotoxicity of compounds from Ulmus davidiana var. japonica.
    Zheng MS; Lee YK; Li Y; Hwangbo K; Lee CS; Kim JR; Lee SK; Chang HW; Son JK
    Arch Pharm Res; 2010 Sep; 33(9):1307-15. PubMed ID: 20945128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and DNA topoisomerases I and II inhibitory constituents from the roots of Aralia cordata.
    Seo CS; Li G; Kim CH; Lee CS; Jahng Y; Chang HW; Son JK
    Arch Pharm Res; 2007 Nov; 30(11):1404-9. PubMed ID: 18087808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis.
    Lee YK; Seo CS; Lee CS; Lee KS; Kang SJ; Jahng Y; Chang HW; Son JK
    Arch Pharm Res; 2009 Oct; 32(10):1409-15. PubMed ID: 19898804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA topoisomerases I and II of compounds from Reynoutria japonica.
    Hwangbo K; Zheng MS; Kim YJ; Im JY; Lee CS; Woo MH; Jahng Y; Chang HW; Son JK
    Arch Pharm Res; 2012 Sep; 35(9):1583-9. PubMed ID: 23054715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory properties of antitumor prostaglandins against topoisomerases.
    Suzuki K; Uyeda M
    Biosci Biotechnol Biochem; 2002 Aug; 66(8):1706-12. PubMed ID: 12353631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juglans mandshurica Maximowicz as a traditional medicine: review of its phytochemistry and pharmacological activity in East Asia.
    Zhao C; Qian X; Qin M; Sun X; Yu Q; Liu J; Zhu Q; Wang A
    J Pharm Pharmacol; 2023 Jan; 75(1):33-48. PubMed ID: 36029200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.
    Umemura K; Mizushima T; Katayama H; Kiryu Y; Yamori T; Andoh T
    Mol Pharmacol; 2002 Oct; 62(4):873-80. PubMed ID: 12237334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070.
    Suzuki K; Doi S; Yahara S; Uyeda M
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):497-503. PubMed ID: 15008514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase-II-inhibitory principles from the stems of Spatholobus suberectus.
    Han AR; Park HJ; Chen D; Jang DS; Kim HJ; Lee SK; Seo EK
    Chem Biodivers; 2007 Jul; 4(7):1487-91. PubMed ID: 17638329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos.
    Li G; Xu ML; Lee CS; Woo MH; Chang HW; Son JK
    Arch Pharm Res; 2004 Aug; 27(8):829-33. PubMed ID: 15460443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.
    Makhey D; Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Apr; 11(8):1809-20. PubMed ID: 12659767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.
    Kim SI; Lee SH; Lee ES; Lee CS; Jahng Y
    Arch Pharm Res; 2012 May; 35(5):785-9. PubMed ID: 22644846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.